Endoplasmic Reticulum Stress Related Molecular Mechanisms in Nonalcoholic Steatohepatitis
Overview
Affiliations
Nonalcoholic steatohepatitis (NASH) is considered to be a common health problem since the incidence of nonalcoholic fatty liver disease (NAFLD) has increased in recent years. Disturbed hepatic cholesterol homeostasis and free cholesterol accumulation in liver results in increased oxidative stress leading to the endoplasmic reticulum (ER) stress. Activated ER stress maintains protein homeostasis however, delayed or inadequate ER stress responses may induce fat accumulation, insulin resistance, inflammation, apoptosis, and autophagy, all of which increase with age and play crucial roles in the pathogenesis of NASH. In aging research, there is a growing interest for the role of ER stress in the progression of NASH since aging seems to favor NAFLD according to its pathogenesis. On the other hand, specific microRNAs (miRNAs) expression profiles are strongly related with ER stress as well as NASH progresses. This review highlights molecular mechanisms related to ER stress in the pathogenesis of NASH and miRNAs for the progression and treatment of the disease.
Role of the FOXM1/CMA/ER stress axis in regulating the progression of nonalcoholic steatohepatitis.
Ma S, Xia E, Zhang M, Hu Y, Tian S, Zheng X Clin Transl Med. 2025; 15(2):e70202.
PMID: 39924645 PMC: 11807764. DOI: 10.1002/ctm2.70202.
Gut Microbiota at the Crossroad of Hepatic Oxidative Stress and MASLD.
Termite F, Archilei S, DAmbrosio F, Petrucci L, Viceconti N, Iaccarino R Antioxidants (Basel). 2025; 14(1).
PMID: 39857390 PMC: 11759774. DOI: 10.3390/antiox14010056.
The role of metabolic reprogramming in liver cancer and its clinical perspectives.
Lu M, Wu Y, Xia M, Zhang Y Front Oncol. 2024; 14:1454161.
PMID: 39610917 PMC: 11602425. DOI: 10.3389/fonc.2024.1454161.
Charan H, Dwivedi D, Khan S, Jena G Genes Dis. 2023; 10(2):480-494.
PMID: 37223529 PMC: 10201559. DOI: 10.1016/j.gendis.2021.12.006.
Molecular and Clinical Links between Drug-Induced Cholestasis and Familial Intrahepatic Cholestasis.
Vitale G, Mattiaccio A, Conti A, Berardi S, Vero V, Turco L Int J Mol Sci. 2023; 24(6).
PMID: 36982896 PMC: 10057459. DOI: 10.3390/ijms24065823.